Medicenna Therapeutics Corp is a biotechnology business based in the US. Medicenna Therapeutics shares (MDNA) are listed on the NASDAQ and all prices are listed in US Dollars. Medicenna Therapeutics employs 13 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Medicenna Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MDNA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Medicenna Therapeutics stock price (NASDAQ: MDNA)Use our graph to track the performance of MDNA stocks over time.
Medicenna Therapeutics shares at a glance
|Latest market close||$3.89|
|52-week range||$2.01 - $6.84|
|50-day moving average||$3.26|
|200-day moving average||$3.76|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Buy Medicenna Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Medicenna Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Medicenna Therapeutics price performance over time
|1 week (2021-07-13)||N/A|
|1 month (2021-06-24)||18.96%|
|3 months (2021-04-20)||N/A|
|6 months (2021-01-20)||N/A|
|1 year (2020-07-20)||N/A|
|2 years (2019-07-20)||N/A|
|3 years (2018-07-20)||N/A|
|5 years (2016-07-20)||N/A|
Medicenna Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-27.1%|
|Return on equity TTM||-46.54%|
|Market capitalisation||$124.5 million|
TTM: trailing 12 months
Shorting Medicenna Therapeutics shares
There are currently 198,214 Medicenna Therapeutics shares held short by investors – that's known as Medicenna Therapeutics's "short interest". This figure is 34% down from 300,302 last month.
There are a few different ways that this level of interest in shorting Medicenna Therapeutics shares can be evaluated.
Medicenna Therapeutics's "short interest ratio" (SIR)
Medicenna Therapeutics's "short interest ratio" (SIR) is the quantity of Medicenna Therapeutics shares currently shorted divided by the average quantity of Medicenna Therapeutics shares traded daily (recently around 161149.59349593). Medicenna Therapeutics's SIR currently stands at 1.23. In other words for every 100,000 Medicenna Therapeutics shares traded daily on the market, roughly 1230 shares are currently held short.
However Medicenna Therapeutics's short interest can also be evaluated against the total number of Medicenna Therapeutics shares, or, against the total number of tradable Medicenna Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Medicenna Therapeutics's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Medicenna Therapeutics shares in existence, roughly 0 shares are currently held short) or 0.0053% of the tradable shares (for every 100,000 tradable Medicenna Therapeutics shares, roughly 5 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Medicenna Therapeutics.
Find out more about how you can short Medicenna Therapeutics stock.
Medicenna Therapeutics share dividends
We're not expecting Medicenna Therapeutics to pay a dividend over the next 12 months.
Medicenna Therapeutics share price volatility
Over the last 12 months, Medicenna Therapeutics's shares have ranged in value from as little as $2.01 up to $6.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Medicenna Therapeutics's is 0.5762. This would suggest that Medicenna Therapeutics's shares are less volatile than average (for this exchange).
Medicenna Therapeutics overview
Medicenna Therapeutics Corp. , a clinical stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase 2b clinical trial for the treatment of recurrent glioblastoma (rGBM), as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA55, which has completed Phase 2b clinical trial to treat rGBM; MDNA109, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease (GvHD); MDNA413, a dual IL-4/IL-13 antagonist to treat solid tumors; and MDNA132, an IL-13 Superkine to chimeric antigen receptor T (CAR-T) platform. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, or naked IL-2, IL-4, and IL-13 Superkines. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Stocks similar to Medicenna Therapeutics
Medicenna Therapeutics in the news
Stocks That Hit 52-Week Lows On Friday
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Stocks That Hit 52-Week Lows On Thursday
Frequently asked questionsWhat percentage of Medicenna Therapeutics is owned by insiders or institutions?
Currently 30.273% of Medicenna Therapeutics shares are held by insiders and 10.246% by institutions. How many people work for Medicenna Therapeutics?
Latest data suggests 13 work at Medicenna Therapeutics. When does the fiscal year end for Medicenna Therapeutics?
Medicenna Therapeutics's fiscal year ends in March. Where is Medicenna Therapeutics based?
Medicenna Therapeutics's address is: 2 Bloor Street West, Toronto, ON, Canada, M4W 3E2 What is Medicenna Therapeutics's ISIN number?
Medicenna Therapeutics's international securities identification number is: CA58490H1073
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert